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Summary
To test whether unprimed CD8+ cells can recognize class I alloantigens presented selectively
on non-bone marrow (BM)-derived cells, unprimed parental strain CD8+ cells were transferred
to long-term parent - Fl BM chimeras prepared with supralethal irradiation . Host class I
expression in the chimeras was undetectable on BM-derived cells and, in spleen, was limited
to low-level staining of vascular endothelium and moderate staining of follicular dendritic cells
(a population of nonhemopoietic cells in germinal centers) . Despite this restricted expression
of antigen, acute blood-to-lymph recirculation of parental strain T cells through the chimeras
led to selective trapping of 95% ofCD8+ cells reactive to normal F1 spleen antigen presenting
cells (APC) in vitro . Subsequently, a small proportion of the trapped cells entered cell division
and gave rise to effector cells expressing strong host-specific CTL activity. The activation of
host-specific CD8+ cells was also prominent in double-irradiated chimeras, and cell separation
studies showed that the effector cells were generated from resting precursor cells rather than
from memory-phenotype cells . It is suggested that the non-BM-derived cells in the chimeras
acted as semiprofessional APC . These cells were nonimmunogenic for most host-reactive CD8+
cells but were capable of stimulating a small subset ofhigh-affinityT cells . The possible relevance
of the data to the prolonged immunogenicity of vascularized allografts in humans is discussed .
T cell responses leading to allograft rejection are initiated
predominantly by BM-derived cells, especially dendritic
cells (DC)l (1-3) . These cells migrate from the graft to the
T-dependent areas of the lymphoid tissues and cause "cen-
tral" sensitization of recirculating host T cells (4) . In accor-
dance with the notion that graft rejection is controlled by
BM-derived (BMD) cells, it is well established that removing
these "passenger leukocytes" from the grafts generally leads
to long-term survival (1) . This finding also applies when grafts
are selectively depleted of DC (5) .
Although depleting grafts ofBMD cells is often highly
efficient in causing graft acceptance in rodent models, this
approach is less successful in clinical transplantation (6, 7)
and also in a pig model (8) . This finding might reflect that
the procedures used to deplete BM-derived cells from large
allografts, e.g ., kidneys, are relatively inefficient . Neverthe-
less, it is notable that patients receiving vascularized allografts
have a high risk of rejection for many years and are usually
i Abbreviations used in this paper. BMC, bone marrow chimeras ; BMD,
bone marrow-derived; CTLpf, cytotoxic T lymphocyte precursor frequency ;
DC, dendritic cells ; FDC, follicular dendritic cells ; HSA, heat-stable antigen ;
LDA, limiting dilution analysis ; MO, macrophage ; NBMD, non-bone
marrow-derived; PALS, periarteriolar lymphocyte sheaths ; PNA, peanut
agglutinin ; TDL, thoracic duct lymph .
maintained permanently on immunosuppression. This long-
term propensity for graft rejection is surprising because typ-
icalDC appear to be relatively short-lived cells (9) . So, which
cells provide the stimulus for late graft rejection? In the case
of large vascular grafts, there is considerable interest in the
idea that certain non-BM-derived (NBMD) cells can play a
role in T cell sensitization (10) . In contrast to the rat, fresh
human endothelial cells express MHC molecules and these
cells are reported to be immunogenic for unprimed T cells
in vitro (11, 12) .
Most of the evidence on the immunogenicity of NBMD
cells has come from studies with IFN- ,y-induced cell lines
passaged in vitro. A key issue is whether unprimed T cells
can be stimulated by NBMD cells under physiological con-
ditions in vivo . We have approached this question by studying
the effects of transferring parent a T cells to a -> (a x b_)Fi
BM chimeras (BMC) prepared with supralethal irradiation
(1,300 cGy) (13) . Such parent - FtBMC show rapid clear-
ance of hostBMD cells and, by 2mo after transfer, hostMHC
(Ia) expression is limited to low-level staining of vascular en-
dothelium and follicular dendritic cells (FDC) (a population
ofNBMD cells in germinal centers) . In previous studies, we
reported that the environment of parent - Fl BMC is
relatively nonimmunogenic for parental strain CD4+ cells,
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priming (13) .
In this paperwe show that transferring unprimed parental
strain CD8+ cells to long-term parent - Ft BMC induces
specific trapping (sequestration) of 95% of CD8+ cells reac-
tive to normal Fl spleen cells in vitro. In addition, a small
proportion of the trapped CD8+ cells are induced to divide
and differentiate into effector cells with highly potent CTL
function within 4 d. The data thus imply that, under in vivo
conditions, NBMD cells can act as "semiprofessional" APC.
These cells are highly efficient in causing T cell trapping but
are also able to induce a small proportionofT cells to differen-
tiate into effector cells. We speculate that these latter cells
represent a subset of high-affinity cells.
Materials and Methods
Mice.
￿
C57BL/6 (136), B6.PLThy 1'/Cy (Thy 1.1), CBA/CaJ
(CBA), (136 x CBA)FI , B10.BR, 1310.132, (136 x B10.D2)Fl, (136
x B10.BR)F,, and (B10.BR x B10.D2)F, mice were bred at the
Scripps Research Institute.
Irradiation.
￿
Mice were exposed to various doses of-y-irradiation
from a 1'7CS source (80 cGy/min) delivered by an irradiator (Gam-
macell 40; Atomic Energy of Canada, Ottawa, Canada). Cellswere
irradiated with an irradiator (Gammacell 1000; Atomic Energy of
Canada) (450 cGy/min).
Media.
￿
HBSS supplemented with 2.5% gamma globulin-free
horse serum (Gibco Laboratories, Grand Island, NY) was used for
preparation of single cell suspensions. DME supplemented with
10% FCS (Irvine Scientific, Santa Ana, CA), 5% NCTC-109, 2
mM glutamine, 5 x 10-5 M 2-ME, and antibiotics was used for
in vitro culture. Phenol red free HBSS supplemented with 1%
gamma globulin-free horse serum and0.1% sodium azide (Sigma
Chemical Co., St. Louis, MO) was used for immunofluorescence
staining.
mAbs.
￿
mAbs specific for Thy 1 (T24, rat IgG) (14); Thy 1.2
(Jlj,ratIgM) (15); Thy 1.1 (19E12, mouse IgG) (16); CD4 (GK1.5,
rat IgG andRL172, ratIgM) (17, 18); CD8 (YTS169, rat IgGand
3.168.8, rat IgM) (19); heat-stable antigen (HSA) alld, rat IgM)
(15); Kk (12.2.2s, mouse IgM (20); Db (28-14-8s, mouse IgG) (21);
I-Ak (10-2.16, mouse IgG) (22); I-Ab (28-16-8s, mouse IgM) (21);
amacrophage (MO) marker (F4/80, rat IgG) (23); IL2R p55 (7134,
rat IgM) (24); and MEL14 (rat IgG) (25) were prepared as ascites
fluid or culture supernatant. mAb for FDC (FCD-M1, rat IgG)
wasagift from Dr. M. Kosco (Basel Institute, Basel, Switzerland),
andmAbs for CD44 (KM201, rat IgG) (26) and very late antigen
(VLA)-4cx (PS/2, rat IgG) were kindly provided by Drs. K. Miyake
and Dr. P. W. Kincade (Oklahoma Medical Research Foundation,
Oklahoma City).mAb forCD45RB (23G2, ratIgG) (Pharmingen,
SanDiego, CA) andPE-conjugated anti-CD8 mAb (Gibco Labora-
tories) were purchased.
Preparation ofBMC.
￿
8-12-wk-old (136 x CBA)F, mice were
exposed to 1,300cGy-y-irradiation and then injected intravenously
with 4-8 x 106 antiThy 1 mAb plus C-treated B6.PL BM cells
(13). 2-6 d later the hosts received a cocktail of anti-T cell mAbs
(YTS169, GK1.5, andT24ascitesfluid) to eliminateradio-resistant
Tcells.At 6 mo afterreconstitution, some BMC received a second
dose of irradiation (900 cGy) followed by reconstitution with
T-depleted B6 BM and further in vivo treatment with anti-T cell
mAbs. All BMC were maintained on antibiotics added to the
drinking water.
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Purification of T Cell Subsets.
￿
For cell transfer, T cells were
purified from LN using pooled cervical, axillary, inguinal, sub-
scapular, andmesenteric nodes. To deplete non-T cells, LN suspen-
sions were treatedwith anti-HSA and anti-I-A mAbplus Cin vitro
at 37°C, and then washed before injection. To prepare purified
CD8+ cells for MLR and CTL assays, lymph-borne cells were
treated with a mixture of anti-HSA, anti-I-Ab and anti-CD4
(RL172) mAbplus Cbefore use. In some experiments, T cells were
separated on stepwise Percoll (Pharmacia, Uppsala, Sweden) den-
sity gradients as described elsewhere (27).
TCellSelection in Irradiated Hosts.
￿
As describedelsewhere(13),
long-termBMC and control mice were exposedto 950cGy irradi-
ation and injected intravenously 4-6 h later with 0.8 - 108 purified
T cells. Cannulas were placed in the thoracic duct 10-12 h later
and thoracic duct lymph (TDL) was collected on ice forup to 5 d.
Lymph-bornecells collected from twoto four mice pergroup were
stained for surface markers and treated with anti-CD4 mAb plus
C forin vitro assays. For staining analysis, anyresidual donorBM-
derived Tcells were gatedout with theaidofbiotinylated antiThy
1.1 mAb (see FRCS® analysis). For functional assays, these T cells
were removed with antiThy 1.1 mAb plus C.
MLR.
￿
As described previously (28), doses of 0.4-1.6 x 105
responder cells were cultured in microtiter plates with 5 x 105
2,000 cGy-irradiated spleen cells as stimulators in a volume of 200
Al for 84 h. Triplicate cultures were pulsed with 1 114Ci ['H]TdR
during the last 12 h of culture.
In Vitro Generation ofCTL.
￿
To generate CTLin bulk cultures,
doses of 106 purified CD8+ cells from TDL were cultured with
4 x 106 2,000 cGy-irradiated (B10.BR x B10.D2)F, spleen cells
in 2-ml wells together with 2% supernatant from stimulated E14
cells as a source of lymphokines. EL4 cells were kindly provided
by Dr. O. Kanagawa (Washington University Medical School, St.
Louis, MO). After5 d, the cultures were harvested, counted, and
tested for lysis of 10" "Cr-labeled target cells. Target cells were pre-
pared by stimulating B6, B10.BR, or B10.D2 spleen cells for 64 h
with 2.5 hg/ml Con A and 10% (vol/vol) stimulated EL4 super-
natant. "Cr-release was measured after 4 h, using 0.5% Triton
X-100 to measure maximal"Cr-release. The percent specific lysis
was calculated by standard techniques. Spontaneous release was
always <20% of maximal release.
Limiting dilution analysis (LDA) was used to measure CTL
precursor frequency. LDA was performed as described elsewhere
(29). For each dose of responder cells, T cells were plated in 48
replicate cultures containing 5 x 105 (B6 x B10.BR)F, or (136
x B10.D2)F, stimulator cells with 2.0% stimulated EL-4 super-
natant in 0.2 ml volumes. CTLactivity was tested usingboth syn-
geneic and specific target cells. Precursor frequencies were deter-
mined according to Poisson distribution .
To measure direct CTL activity of in vivo-stimulated T cells,
TDL cells were washed and then tested immediately for lysis of
"Cr-labeled Con A blasts or 2C11 B hybridoma cells (30) as de-
scribed above.
Assayfor Lethal GVHD
￿
Unless stated otherwise, host mice
were exposed to 500 cGyirradiation severalhours before transfer
of donor Tcells. Antibiotics were given in the drinking water for
the first 6 d, and the host mice were inspected daily until death.
The day of death was defined as the dayon which mice were un-
able to take food or water. Such mice werekilled to prevent suffering.
FACS®Analysis.
￿
TDL cells were incubated with various un-
conjugated mAbs specific formemory/activation markers, followed
by FITC-labeled mouse F(ab)2 anti-rat IgG (H+L) (Jackson Im-
munoResearch Laboratories, West Grove, PA), goat F(ab)2
anti-mouse Fcy (CappelLaboratories, Durham, NC), or rat F(ab)2anti-mouse Ig (Jackson ImmunoResearch Laboratories), according
to the class of the unconjugated mAbs. After blocking of free
binding sites by rat and/or mouse normal sera, cells were stained
with PE-conjugated anti-CD8 mAb. For early lymph collections,
any residual BM-derived cells were gated out with the aid of bi-
otinylated antiThy 1.1 mAb and streptavidin RED613 (Gibco
Laboratories) . Dead cells were stained with propidium iodide (Sigma
Chemical Co .) and gated out for analysis . Stained cells were ana-
lyzed on a FACScan® (Becton Dickinson & Co., Mountain View,
CA) . All instrument settings and the markers used for each staining
were fixed during the course of each experiment .
Immunohistochemistry .
￿
Freshly cut 5-um cryostat sections were
stained as described (31) . Briefly, cryostat sections were acetone fixed
and incubated with pretitrated concentrations of unconjugated or
biotinylated antibodies or biotinylated peanut agglutinin (PNA)
(Biomeda, Foster City, CA), washed and incubated with either
peroxidase-conjugated streptavidin or anti-rat IgG (Jackson Im-
munoResearch Laboratories) . For staining with the unconjugated
mAb F4/80, an intermediate incubation step with biotinylated
anti-rat IgG (Jackson ImmunoResearch) was used. After staining,
sections were washed and and developed with the substrate 3-amino-
9-ethylcarbazole (31) . Sections were mounted and photographed
using a green filter.
Results
Experimental Design .
￿
Parent - Ft BMC were prepared
by exposing (136 x CBA)F, (H-2b x H-2k) mice to 1,300
cGy and then reconstituting the mice intravenously with
T-depleted Thy 1-marked B6.PL (H-2b, Thy 1 .1) BM cells .
Within 1 wk, the mice were injected with a mixture ofantiT
cell mAb to remove residual radioresistant host T cells . The
chimeras were left for at least 6mo before use asT cell hosts .
Some chimeras received a second course of irradiation and
BM reconstitution 6 mo after transfer and were used 2-3 mo
later. Unless stated otherwise, all chimeras and control hosts
were conditioned with 900 cGy just before T cell transfer.
Histology .
￿
In previous studies, spleen and thymus suspen-
sions from long-term parent - Fl chimeras were found to
be completely devoid ofhost-typeAPC in terms of stimulating
MLR in vitro (32) . In sections, mononuclear cells expressing
a high density of host H-2 class II molecules were undetect-
able in spleen, LN, skin, and gut (13, and our unpublished
results) . Host class II expression was limited to low-level
staining of vascular endothelium and a subset of germinal
center cells ; the latter were presumed to be FDC (a class of
NBMD cells) . Class I expression was not examined.
Host class I (Kk) expression in the spleen of parent - Fl
chimeras is shown in Fig. 1 . In striking contrast to normal
(136 x CBA)F, mice which display strong class I (Kk) ex-
pression throughout the spleen (Fig. 1 A), host Kk expres-
sion in B6.PL - (136 x CBA)F, BMC is limited to low-
level staining ofvascular endothelium and quite strong staining
of germinal centers (Fig. 1, C and D) . The staining of ger-
minal centers is probably restricted to FDC because in serial
sections an essentially similar pattern of staining is seen with
an FDC-specific antibody (Fig. 1 F) . The germinal center
areas are PNA+ (Fig. 1 E) and also express host class II (I-
Ak) molecules (13, and Fig. 1 G) . The possibility that ra-
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dioresistant host MO accounted for the staining in germinal
centers seems most unlikely because, as detected by F4/80
expression, MO are restricted to the red pulp (Fig . 1 H) .
Negative Selection.
￿
As discussed elsewhere (13), the tech-
nique ofacute blood-to-lymph recirculation ofT cells through
allogeneic hosts is a highly sensitive method of studying the
earliest stages of allorecognition. When parental strain T cells
are transferred to irradiated F l hybrid mice, T cells with host
reactivity migrate to the lymphoid tissues and contact host
BMD cells, presumably DC. Recognition ofMHC antigens
on DC traps the host-reactive T cells, with the result that
the donor T cells entering TDL are selectively depleted of
host reactivity . This period of negative selection lasts for 1-2 d
after transfer and affects both CD4+ and CD8+ T cells .
To study trapping of parental strain CD8+ cells inBMC
hosts, long-term B6.PL - (136 x CBA)F, BMC (hence-
forth termed B6.PL - Fl BMC) were exposed to 900 cGy
and injected intravenously 2-4 h later with a large dose of
unseparated B6LNT cells. Lymph-borne cells were collected
16-32 h after T cell injection, and donor-derived CD8+ cells
were purified by mAb plus C treatment (see Materials and
Methods). The data in Table 1 show primary MLR of B6
CD8+ cells after blood-to-lymph recirculation through nor-
mal B6.PL mice vs . B6.PL - Fl BMC . MLR were mea-
sured in vitro using normal spleen cells as stimulators. As
expected, B6 CD8+ cells filtered through H-2 (H-2b)-iden-
tical B6.PL hosts gave high MLR to Fl stimulator cells ex-
pressing H-2k or H-2d antigens. The surprising finding was
that filtering B6 CD8+ cells through B6.PL - Fl BMC
caused complete removal of the host-reactive cells : the lymph-
borne CD8+ cells responded strongly to third-party H-2d
spleen cells, but gave no detectable response to H-2k spleen
cells . The same finding occurredwhen twice-irradiatedBMC
were used as hosts (Table 1) .
Similar data were obtained when trapping was measured
in terms of CTL precursors. As shown in Fig. 2 A, B6
CD8+ cells filtered through syngeneic B6.PL hosts gener-
ated strong CTL activity against both H-2k (1310.13R) and
H-2d (1310.132) target cells after stimulation with (B10.BR
x B10.D2)Fl spleen stimulators in vitro . By contrast, B6
CD8+ cells filtered through the BMC generated only H-2d-
reactive CTL and not H-2k-reactive CTL .
The above data refer to CTL generated in bulk cultures .
To seek quantitative information on the extent of trapping
in BMC hosts, we used LDA . This approach gives an ac-
curate estimate of CTL precursor frequency (CTLpf) . As
shown in Fig . 2 B and Table 2, in vitro stimulation of B6
CD8+ cells filtered through B6 .PL mice generated a high
CTLpf for both H-2k and H-2d (about 1% for each) .
Filtering B6 CD8+ cells through normal Fl hosts reduced
the CTLpf for H-2k by 2 logs but caused only a small reduc-
tion in the CTLpf for H-2d . Based on the ratio of CTLpf
for H-2k vs . H-2d (Table 2), there was a >99% specific
reduction in CTLp for H-2k . Very similar findings applied
when B6 CD8+ cells were filtered through B6.PL -> Fl
BMC. Evenwhen the BMC were conditioned with two doses
ofBM plus irradiation, there was a 94% specific reduction
in CTLp for H-2k (Table 2) .Table 1 .
￿
MLR by B6 CD8' Cells Filteredfrom Blood to Lymph through B6.PL- F, BMC Hosts for 16-32 h : Complete
Unresponsiveness to Host H-2k Antigens
(1,300 + 900 cGy)
Normal B6.PL mice and long-term BMC prepared with one or two doses of irradiation plus BM were injected intravenously with 108 B-depleted
B6 LN T cells 4 h after exposure to 900 cGy . Thoracic duct cannulation was performed 10-12 h later and the donor cells were collected from TDL
from 16-32 h after injection. The lymph-borne T cells were treated with a mixture of anti-CD4, anti-HSA, anti-I-A and anti-Thy 1.1 mAb plus
C to prepare purified donor-derivedCD8' cells . These cells were used as responder cells for MLRusing irradiated (2,000 cGy) spleen cells as stimu-
lators . MLR were measured on day 3 .
' Mean response of triplicate cultures .
Theabove data indicate that thelimited expression of host
class I antigens on the stromal (NBMD) cells ofBMC is highly
efficient at causing trapping of CD8+ cells. In considering
this finding, it is important to emphasize that T cell trap-
ping in the lymphoid tissues is not necessarily followed by
overt stimulation (cell division) . In normal Fl hosts where
antigen is presented by DC, -50% of the trapped host-
reactive cells fail to divide (33) . Theremaining cells proliferate
extensively andreenterthe circulation as blast cells. This stage
of positive selection begins at about 2 d after transfer and
reaches a peak at 4-5 d (13) . Positive selection ofCD8+ cells
in BMC hosts is discussed below .
Positive Selection .
￿
In the case ofCD8+ cells, positive se-
lection of parental strain T cells in normal Fl hosts generates
large numbers of circulating CD8+ blast cells with direct
CTL activity (34, 35). These blasts cause rapid lysis of "Cr-
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labeled host-type target cells in vitro. This is illustrated in
Fig. 3, C andD where it can be seen that at day 3 (69-82
h) andday 4 (90-106 h) after transfer ofB6Tcells to normal
Ft hosts, the donor cells in TDL were highly efficient at
causing direct lysis of target cells expressing host-type class
I antigens (B10.BR, H-2k) in vitro. Lysis ofB10.BR targets
was somewhat higher on day 4 than on day 3. Lysis of syn-
geneic (B6) targets was negligible (Fig. 3, A and B) .
With transfer of B6 T cells to B6.PL - Fl BMC, the
donor CD8+ cells recovered from TDL on day 3 caused
only low-level lysis of B10.BR targets (Fig. 3 C) . At later
stages, however, theCTL activity of the lymph-borne cells
increased dramatically . Thus, by day4 after transfer, the anti-
B10.BR CTL activity of T cells stimulated in BMC hosts
was appreciably higher than forT cells stimulated in normal
Fl hosts (Fig. 3 D) . The generation of strong CTL activity
Figure 1 .
￿
Host class I expression in spleens of normal (B6 x CBA)F, and long-termB6.PL -" (B6 x CBA)F, BMC. Cryostat sections of spleens
were stained as described in Materials andMethods. Except forA and C, serial sections are shown . All sections were photographed at x 100 except
C. (A) Normal F, stained for Kk ; staining is evident throughout the spleen with strong expression on the DC in periarteriolar lymphocyte sheaths
(PALS), the B cells in the follicles (f), and the M45 in the marginal zone (mz) and the red pulp (rp) . (B) BMC stained for Db (donor class I) . As
in A, staining is evident throughout the spleen. (C) High power (x160) view of BMC stained for Kk (host class I) . There is strong staining of
a follicle/germinal center and weak staining of the red pulp sinusoids (arrowheads), whereas the PALS is conspicuously negative. (D) BMC stained
for Kk (host class I) . Three areas of strong germinal center staining are seen in the outer white pulp. There is moderate staining of vascular en-
dothelial cells in the marginal zone (arrowheads) and the central arteriole (ca), whereas the PALS and the red pulp are largely negative . (E) BMC
stained with PNA. Strong staining of germinal centers in the outer white pulp is evident (compare with D) . (F) BMC stained with an FDC-specific
mAb FDC-Ml . The pattern of staining in the outer white pulp closely resembles staining for Kk and PNA . (G) BMC stained for I-Ak (host class
II). Staining is limited to germinal center areas and vascular endothelial cells. (H) BMC stained for F4/80 (MO) . Staining is restricted to the marginal
zone and the red pulp with no staining in the white pulp. (I) BMC stained with an irrelevant mAb. Staining is limited to cells with endogenous
peroxidase activity. These cells are most prominent in the red pulp, but are also found in the PALS.
Filtration hosts
for B6 CD8' cells
No . of responder
cells for
MLR (x 10 5)
136
H-2b
[3H]TdR incorporation
irradiated spleen
(B6 x CBA)F,
H-2bxk
(cpm x 103) with
stimulators
(B6 x B10.D2)F,
H-2bxd
Normal B6.PL 1.6 0.2" 65.4 67.0
0.8 0.1 37.5 46 .5
0.4 0.1 9.7 12.7
B6.PL -> F, BMC 1.6 0.3 0.5 57.6
(1,300 cGy)
B6.PL- F, BMC 1.6 0.1 0.2 64.8A
B
d 0 .37
10 100 01 ., , 10 100 01 , 1 10 100
E / T ratio E % T ratio
￿
E / T ratio
Responder cells / well
￿
Responder cells / well
￿
Responder cells / well
0 200 400 600 800 0 1600 3200 4800
B6
See Fig . 1 legend and Materials and Methods for details .
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Figure 2 .
￿
Acute blood-to-lymph recirculation of B6 T cells through
irradiated long-term B6.PL --> F, BMC selectively removes CTL
precursors specific for host class I antigens . Normal B6 T cells were trans-
ferred intravenously to normal B6.PL mice (O), normal (136 x CBA)F 1
mice (0), and long-term B6.PL -> F, BMC (A) . The hosts were condi-
tioned with 950 cGy 4-6 h beforeT cell transfer. Donor cells were col-
lected from TDL of the host mice 16-32 h later and treated with anti-
HSA mAb and anti-CD4 mAb plusC to prepare CD8' cells. (A) Lymph-
borne B6 CD8' cells were stimulated with (B10.BR x B10.D2)F, (H-2k
x H-2d) spleen stimulators in vitro for 5 d in bulk cultures and then
tested for lysis of 51Cr-labeled B6 (syngeneic), B10.BR (host), and 1310.132
(third-party) Con A blasts as target cells. Specific 51Cr-release for tripli-
cate cultures is known . (B) CTLpf were measured byLDA . Graded doses
of lymph-borne CD8' cells were cultured with (136 x CBA)F, spleen
Table 2 .
￿
Acute Blood-to-Lymph Recirculation of B6 CD8' Cells through Long-Term B6.PL - Ft BMC: CTL Precursor
Frequencies in CD8' Cells Recovered at 16-32 h after Injection
CTLpf ( x 10- ^) for
target cells
Stimulation of CD8' Cells by Nonhemopoietic APC
in BMC hosts also applied to BMC prepared with double
irradiation (Fig . 3, C and D) . CTL activity was specific for
B10.BR targets, lysis ofB6 targets being very low. No lysis
ofB10.BR targets occurred when B6T cells were transferred
to syngeneic B6.PL mice (Fig . 3, C and D) .
Similar results were found in a second experiment in which
CTL activity in TDL was monitored sequentially on days
3, 4, and 5 after transfer (Fig. 4) . In this experiment, it can
be seen that the CTL activity ofT cells generated in normal
F, hosts increased progressively from days 3 to 5 (Fig. 4,
D-F) . For T cells transferred to BMC hosts, CTL activity
for B10.BR targets was lower than the control T cells on
day 3, higher on day 4, and equivalent on day 5 . On days
4 and 5, the CTL from both groups of mice caused equiva-
lent nonantigen-specific (redirected) lysis ofthe anti-CD3 hy-
bridoma, 2C11 .
Hourly outputs of cells collected from TDL during the
course of the above experiment are shown in Fig . 4,J-L .
With T cell transfer to syngeneic hosts, cell outputs remained
low throughout the experiment . By contrast, with cell transfer
to normal F 1 hosts, cell yields were clearly elevated on day
3, and reached peak values on days 4 and 5 . WithBMC hosts,
cell yields were low on day 3 but then increased significantly
on days 4 and 5 . At this stage, cell outputs were three to
fourfold higher than in the control B6 - B6.PL group.
Nevertheless, cell yields from theBMC hosts were about six-
fold lower than from the normal F1 hosts . These data refer
to total T cells . For both the BMC and normal F, group,
stimulators . After 7 d, the cells in each well were split into two portions
and tested for lysis of B10.BR and B6 targets. In parallel, B6 CD8' cells
were cultured for 7 d with (136 x B10.D2)F1 stimulators and then tested
for lysis of 1310.132 and B6 targets . Note that, to prevent overcrowding
of the data in the figure, the scale for lysis ofB10.D2 targets (bottom right)
is different than for B10.BR and B6 targets .
Expt .
Irradiated hosts used for acute blood-
to-lymph recirculation of B6 T cells
B6
(H-2 b)
B10.BR
(H-2k)
1310.132
(H-2d)
Ratio of response
to B10.BR vs .
B10 .D2
Percent specific reduction
of response to
B10.BR
1 Normal B6.PL <0.3 140.0 120 1 .17 -
Normal (136 x CBA)F1 <0.3 0.6 90 <0.01 >99
B6.PL - F 1 BMC (1,300 cGy) <0.3 5.0 120 0.04 97
2 Normal B6.PL <0.3 120.0 110 1.09 -
Normal (136 x CBA)F 1 <0.3 0.4 60 <0.01 >99
B6 .PL - F, BMC (1,300 cGy) <0.3 4.0 90 0.04 96
B6 .PL --> F 1 BMC (1,300 + 900 cGy) <0.3 5 .0 80 0.06 94
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Figure 3 .
￿
Direct CTL activity by lymph-borne CD8+ cells collected
from B6.PL - F1 BMC at days 3 and 4 after injection of normal B6 T
cells. B6 T cells were transferred to normal B6.PL mice (O), normal F1
mice ((]), and long-term B6.PL- F1BMC prepared with either a single
dose of 1,300 cGy (A) or two consecutive doses of 1,300 cGy and 900
cGy (" ) . Mice ofeach group received 950 cGy 4-6 h before T cell transfer.
Thoracic duct cannulas were inserted at 12 h after injection and lymph
was collected continuously thereafter. The data show directCTL activity
for 51Cr-labeled B6 and B10.BR Con A blast target cells in vitro for
CD8* cells collected from TDL at 69-82 h (left) and 90-106 h (right)
after initial T cell injection. Specific 51Cr-release for triplicate cultures is
shown .
the proportion of CD8+ cells in TDL increased progres-
sively from days 3 to 5, reaching 70-80% on day 5 (see Fig.
4 legend) .
Fig. 5 shows the phenotype ofCD8+ cells recovered from
TDL of the above three groups of host mice at days 1-5 after
T cell injection . In the case of CD8+ cells entering the
lymph of the control B6 - B6 .PL group, the vast majority
of the cells in each lymph collection displayed the typical pheno-
type of recirculating virgin/resting T cells, i .e ., CD45RBhi,
MEL14hi, and Pgp-1 (CD44) 1° . With T cell transfer to nor-
mal Ft hosts, nearly all of the cells recovered during the
stage of negative selection (<32 h) had a resting phenotype .
Thereafter, the lymph contained increasing proportions of
blast cells expressing a memory/activated phenotype, i .e .,
CD45RB1°, MEL1410, and Pgp-1hi cells . By day 4-5, nearly
all of the cells in the lymph were typical blast cells, most
of which displayed activation markers . With T cell transfer
to BMC hosts, cells with an activated phenotype began to
appear in the lymph at about day 3 after transfer and were
the predominant population by day 5 .
Similar findings applied in a second experiment (Fig. 6) .
In this experiment, BMC hosts prepared with the usual single
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Figure 4 .
￿
DirectCTL activity and total cell counts inTDL ofnormal
B6.PL mice (O), normal Ft mice (0), and long-term B6.PL - F1BMC
(1,300 cGy) (A) at days 3, 4, and 5 after injection of normal B6 T cells
(see Fig . 3) . At each time point, TDL from the three groups ofmice were
tested for direct CTL activity on B6 and B10.BR Con A blasts and also
on the 2C11 cell line (a B hybridoma producing anti-CD3 mAb). Cell
yields in TDL refer to total cells . On days 3, 4, and 5, the proportion
of CD8* cells in the lymph samples was 22, 49, and 72% for the BMC
hosts, and 38, 64, and 79% for the normal F1 group.
dose of irradiation (1,300 cGy) were compared with BMC
hosts prepared with double irradiation (1,300 + 900 cGy) .
For convenience the data are shown in terms of percent posi-
tive cells. Two points emerge from the data . First, the rate
of appearance of CD8+ cells with a memory/activated
phenotype (including IL2R+ cells) in TDL was virtually
identical for thetwo groups ofBMC hosts. Second, the entry
of activated CD8+ cells into TDL of the BMC hosts oc-
curred about 1 d later than in the control normal F l group .
For the BMC group, it should be noted that the rapid in-
crease in the proportion of activated CD8+ cells in the
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Figure 5 .
￿
CD8+ cells entering TDL of long-term B6 --> Ft BMC hosts
injected with B6 T cells begin to show memory/activation markers on
day 3 after transfer. Lymph-borne cells from the three groups of mice in
Fig. 4 werecollected continuously from days 1-5 . At the time ofintervals
shown, aliquots ofcells were stained for expression ofCD8 vs . CD45RB,
MEL14, or Pgp-1 (CD44) .
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Figure 6 .
￿
Similar rate of appearance of activated CD8' cells in TDL
ofBMC hosts prepared with one vs. two doses of irradiation . The data
show CD45RB, MEL14, and IL-2R expression on lymph-borne CD8
cells collected from the four groups ofmice discussed in Fig. 3 . The data
are presented in terms of the percentage of cells expressing the marker
concerned . Cells were stained as described in Materials and Methods.
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lymph between days 3 and 4 corresponded closely with the
marked increase in CTL activity discussed above .
The above findings document that transferring parental
strain CD8+ cells to long-term parent - Fl BMC causes
a small but significant proportion of the donor T cells to
proliferate and differentiate into blast cells with potent anti-
host effector function . Although the donor LN T cells used
in these experiments consisted largely of typical resting T
cells, it remained possible that a minority population of
memory-phenotype cells accounted for the proliferative re-
sponse of the T cells in BMC hosts . To examine this possi-
bility, B6LN T cells were layered on stepwise Percoll density
gradients before injection . High buoyant density T cells were
recovered from the band between the two highest density
layers (p 1.08 and 1.90) ; under the conditions used, only 10%
of the T cells entered this band . As shown in Fig. 7, G-J
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Figure 7 .
￿
CTL activity and surface markers oflymph-borne CD8' cells
collected from BMC hosts injected with high-density T cells. Groups of
B6.PL - Fl BMC were injected with normal B6 T cells (0) or high-
density B6 T cells (" ) prepared on Percoll gradients (Materials and
Methods) . Control normal F, mice received normal B6 T cells (EI) . To
measure direct CTL activity, lymph-borne cells collected on day 3 (A,
C, and E) or day 4 (B, D, and F) after transfer were tested for their ca-
pacity to lyse S 1Cr-labeled B6, B10.BR, and 2C11 target cells in vitro (see
Fig . 4) . To detect activation markers on CD8' cells (G-J), lymph-borne
cells collected on days 2, 3, and 4 after transfer were double stained for
expression of CD8 vs . the four markers shown. Initial expression of the
four markers on CD8' cells in the injected populations of normal B6 T
cells (O) and high-density T cells (" ) is shown on the left side of the figures.
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Figure 8 .
￿
Susceptibility ofBMC to lethalGVHD . (A and B) The host
mice were conditioned with 500 cGy a few hours before T cell transfer.
(C) The host mice were not conditioned with irradiation. The source and
number of T cells injected were as follows . (A) (" ) Normal F l mice given
5 x 106 B6 T cells; (" ) normal Fl mice given 8 x 107 B6 T cells ; (O)
B6.PL -> Fl BMC given 8 x 107 B6 T cells, (x), B6.PL -" F l BMC
given 8 x 107 B6 CD4+ T cells ; and (---) uninfected B6.PL -~ FlBMC
(500 cGy only) . (B) (" ) Normal F, mice given 5 x 107 B6 T cells; (O)
B6.PL- Fl BMC given 8 x 107 B6 T cells, (x), B6.PL- F, BMC
given 5 x 10 7 CBA T cells ; and (E]) B6.PL- F, BMC given 5 x 107
normal F, T cells . (C) (") Normal Fl mice given 5 x 10 7 B6 T cells ;
(O) B6.PL -> FI BMC given 5 x 10 7 B6 T cells; and (- - -) uninfected,
untreated B6.PL - F, BMC.
(left) nearly all of these high-density T cells expressed the
typical markers of virgin/resting T cells .
The results of injecting B6 .PL -> Fl BMC with normal
B6 T cells vs. purified high-density B6 T cells are shown in
Fig. 7 . It is apparent that these two T cell populations were
indistinguishable in terms of generating host-reactive CTL
(Fig . 7, C and D) and forming CD8+ blast cells expressing
activation markers such as IL2R, Pgp-1, and VLA-4 (Fig .
7, G-J) . This was apparent even during the early exponen-
tial phase of the response. The possibility that the activated
cells generated in the chimeras were selectively derived from
memory-phenotype cells contaminating the initialT cell in-
oculum thus seems unlikely.
Susceptibility to GVHD.
￿
The activation and differentia-
tion of parental strain T cells in parent -" Fl BMC consti-
tutes aGVH reaction . To examine whether this reaction pro-
ceeds to overt GVHD, groups of B6.PL -" Fl BMC were
exposed to light irradiation (500 cGy) and injected with large
doses of B6 T cells . The recipients showed signs of acute
GVHD at 1 wk after transfer and all of the mice died within
2 wk (Fig . 8 A) . No deaths occurred in control BMC hosts
given B6 CD4+ cells. Induction of lethal GVHD was thus
CD8+ cell dependent .
In a second experiment, groups of lightly-irradiated B6.PL
--~ Ft BMC were injected with B6 (H-2b) vs . CBA (H-2k)
T cells. Here, the stimulus for GVHD was provided by both
BMD and NBMD cells in the case ofCBA T cells but only
byNBMD cells forB6T cells. In both situations, the recipients
succumbed to lethalGVHD within 2 wk (Fig. 8 B) . No deaths
occurred when (B6 x CBA)F1 T cells were injected.
The above data refer to BMC given irradiation before T
cell transfer. When this conditioning dose of irradiation was
omitted, GVHD induction in B6.PL - Fl BMC recipients
ofB6 T cells occurred more slowly . Nevertheless, all of the
BMC hosts died within 5 wk (Fig. 8 C) . In control experi-
ments, transferring B6 T cells to nonirradiated normal Fl
hosts led to a rapid onset ofGVHD, and all of the mice died
within 2 wk .
Discussion
As mentioned in the introductory section, patients receiving
vascularized allografts remain susceptible to rejection formany
years . The types ofT cells controlling late rejection are not
well defined . Rejection might be controlled principally by
presensitized T cells primed soon after grafting through contact
with graft-derivedDC . Long-livedmemory T cells could cause
rejection episodes by directly attacking the graft or through
lymphokine release . Alternatively, late rejection might be
largely under the control ofnewly-formed naive T cells, sen-
sitization of these T cells being elicited through contact with
NBMD cells in the graft . The present finding that unprimed
CD8+ cells differentiate into effector cells when exposed to
NBMD cells in long-term BMC is consistent with this idea .
One has to consider the possibility that the donor T cells
responded to "processed" antigens in the chimeras, i .e., to
host class I peptides presented by donor-derived APC . This
idea is implausible for three reasons . First, peptides resulting
from the external pathway of antigen processing generally
associate only with class II and not class I molecules (36) .
Second, there is no evidence that T cells reactive to native
class I molecules (plus endogenous peptides) have crossreac-
tive specificity for allo class I peptides presented by self class
I molecules. Third, previous studies showed that the donor-
derived APC from parent- Fl BMC are unable to stimu-
late parental strain T cells in vitro (32) . A more serious
objection is that the immunogenicity of the chimeras was
controlled by residual host BMD cells. This idea seems very
unlikely because host BMD cells were undetectable either in
cell suspensions or in sections (13, 32, and this paper) . All
of the chimeras studied were prepared with very heavy ir-
radiation (1,300 cGy) and were left for at least 6 mo before
use. If significant numbers of host APC survived this treat-
ment, subjecting the chimeras to further irradiation and BM
reconstitution would be expected to cause a reduction in im-
munogenicity . In practice, however, the immunogenicity of
chimeras prepared with one vs. two doses of irradiation was
indistinguishable .
Although host class I expression in the chimeras was quite
limited, it is interesting that acute blood-to-lymph recircula-
tion of parental strain T cells through the chimeras selec-
tively removed >, 95% ofCD8+ cells reactive to normal Fl
spleen cells in vitro . This finding implies that the density
of antigen required to induce trapping of T cells, which is
a manifestation of initial T cell contact with APC, is surpris-
ingly low. The data also imply that, if alloreactivity is directed
predominantly to various endogenous self peptides (rather
than to allo MHC epitopes per se) (37), the overlap of self
peptides between NBMD cells and BMD cells must be ex-
tensive .
Although the selective trapping of host-reactive CD8+
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20cells inBMC recipients approached 100%, only a small propor-
tion of the trapped cells were induced to proliferate . This
is apparent from the finding that the generation of CD8 +
blast cells in the chimeras was quite low, i.e., about sixfold
lower than in normal Ft hosts . Nevertheless, the fact that
the chimeras did stimulate appreciable proliferative responses
and led to the production of CD8+ cells with potent ef-
fector function is highly significant . Blast cells with typical
activation markers appeared in TDL at about 3 d after transfer
and then increased exponentially to account for nearly all
of the lymph-borne cells by day 5 . Since similar findings applied
after injection ofpurified high-density T cells, the possibility
that the effector cells arose selectively from contaminating
memory-phenotype precursors seems most unlikely. The
finding that the chimeras eventually developed lethalGVHD
indicates that the effector cells were functionally relevant under
in vivo conditions. Although most of the experiments in-
volved BMC hosts conditioned with irradiation just before
T cell transfer (to facilitate detection of donor T cells), it
should be noted that omitting this dose of irradiation did
not prevent the induction of lethal GVHD . This finding makes
it unlikely that the immunogenicity of the chimeras depended
upon an adjuvant-like effect of acute irradiation .
It is notable that the effector cells generated in BMC hosts
were extremely potent in terms ofCTL activity . In fact, on
day 4 after injection, the CTL activity of blasts from the
chimeras was higher than for blasts collected from normal
Fl hosts . How can this be explained? The simplest possi-
bility is that overt stimulation ofCD8+ cells in the chimeras
applied only to a minor subset ofcells with the highest affinity
for host class I antigens. Because oftheir high intrinsic affinity,
these T cells avoided the requirement for professional APC
and were able to interact with host NBMD cells with sufficient
avidity to causeT cell triggering and differentiation into CTL .
Cells of average affinity failed to be stimulated and, for this
reason, the CTL generated in the chimeras were skewed to-
wards high affinity cells . In normal Fl hosts, by contrast, T
cell contact with antigen on host DC caused activation of
cells with a wide range of affinities. The average affinity of
CTL generated in these mice was thus lower than in BMC
hosts .
Proving the above model hinges on demonstrating that
CTL generated in BMC hosts do indeed have above-average
affinity. Some support for this idea is provided by the finding
that the enhanced CTL activity of cells from the chimeras
only applied to antigen-specific lysis . Thus, for "redirected"
(nonantigen-specific) lysis of an anti-CD3 hybridoma line,
cells from BMC hosts and normal Fl hosts were indistin-
guishable. Despite this finding, attempts to prove a differ-
ence in affinity on the basis of susceptibility to inhibition
with anti-CD8 mAb have been largely unsuccessful (data not
shown) . For this reason, at present the notion that the CTL
generated in the chimeras represent a subset of high-affinity
cells has to be viewed more as hypothesis than fact .
It should be emphasized that the precise identity of the
NBMD cells controlling APC function in BMC hosts is still
unclear. The level of host class I expression was quite low
in sections and, in spleen, was largely restricted to vascular
endothelium and the FDC of germinal centers . Proving
whether these cell populations express APC function in situ
is difficult . In future experiments, we hope to address this
issue by defining the precise microenvironments in which
CD8+ cells undergo initial blast transformation in BMC
hosts . Since the highest density of host class I (and class II)
was found on FDC, it will be particularly interesting to test
whether the activation of CD8+ cells (and/or CD4' cells)
in chimeras is prominent in germinal centers. Although there
is currently no direct evidence that FDC act as APC for T
cells, it is striking that FDC are a major reservoir for HIV
infection (38), which raises the possibility that the T lym-
phocytopenia in AIDS is a reflection ofT-FDC interaction .
As a final comment, it may be mentioned that our initial
aim in studying allorecognition in BMC hosts was to test
the notion that T cell contact with antigen on nonprofes-
sional APC is nonimmunogenic and leads to tolerance (anergy)
induction (39, 40) . In practice, the finding that T cell con-
tact with antigen in the chimeras led to overt immune re-
sponses made it impossible to assess this idea: the NBMD
APC in the chimeras turned out to be semiprofessional rather
than nonprofessional . Since T cell activation in the chimeras
appeared to be restricted to a minor subset of cells, what hap-
pened to the remainder of the host-reactive cells? Were these
cells rendered anergic or did the cells remain unstimulated?
Further studies will be needed to resolve this important
question .
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